Option Care Health (NASDAQ:OPCH) Given New $40.00 Price Target at Barrington Research

Option Care Health (NASDAQ:OPCH) had its price target hoisted by Barrington Research from $38.00 to $40.00 in a research report sent to investors on Thursday, Benzinga reports. The firm currently has an outperform rating on the stock.

Separately, JMP Securities initiated coverage on shares of Option Care Health in a report on Tuesday, July 16th. They issued an outperform rating and a $36.00 price objective for the company.

Option Care Health Trading Down 5.7 %

Shares of Option Care Health stock traded down $1.80 during trading on Thursday, reaching $29.81. 1,145,336 shares of the stock were exchanged, compared to its average volume of 1,435,586. The company has a quick ratio of 1.39, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. The stock’s fifty day moving average is $29.10 and its 200 day moving average is $30.67. The firm has a market cap of $5.18 billion, a price-to-earnings ratio of 19.55, a price-to-earnings-growth ratio of 2.33 and a beta of 1.24. Option Care Health has a 1 year low of $26.11 and a 1 year high of $35.74.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The business had revenue of $1.23 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the business posted $0.63 earnings per share. Option Care Health’s quarterly revenue was up 14.8% compared to the same quarter last year. As a group, equities research analysts expect that Option Care Health will post 1.21 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

Several institutional investors and hedge funds have recently made changes to their positions in OPCH. Wellington Management Group LLP increased its position in shares of Option Care Health by 157.1% during the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock valued at $250,841,000 after acquiring an additional 4,549,164 shares in the last quarter. Norges Bank bought a new stake in shares of Option Care Health during the fourth quarter valued at approximately $64,343,000. Westfield Capital Management Co. LP increased its position in shares of Option Care Health by 19.6% during the fourth quarter. Westfield Capital Management Co. LP now owns 4,482,732 shares of the company’s stock valued at $151,023,000 after acquiring an additional 735,344 shares in the last quarter. Fort Washington Investment Advisors Inc. OH bought a new stake in shares of Option Care Health during the second quarter valued at approximately $18,774,000. Finally, Riverbridge Partners LLC increased its position in shares of Option Care Health by 49.5% during the fourth quarter. Riverbridge Partners LLC now owns 1,792,012 shares of the company’s stock valued at $60,373,000 after acquiring an additional 593,706 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.